<DOC>
	<DOC>NCT02483793</DOC>
	<brief_summary>The primary objective of this study is to evaluate the efficacy and safety tamsulosin in reducing stent discomfort in the pediatric population in the peri-operative period. The secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in reducing stent discomfort.</brief_summary>
	<brief_title>Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population</brief_title>
	<detailed_description />
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Patients aged 418 years will be enrolled in this study. We will include all patients who will have a ureteral stent placement after their procedure. Patients with developmental delay or unable to verbalize their pain level will be excluded.</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>